Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.05 per share
-
Shares outstanding
-
95,490,450
-
Total 13F shares
-
6,124,463
-
Share change
-
+6,124,463
-
Total reported value
-
$211,832,000
-
Price per share
-
$34.59
-
Number of holders
-
44
-
Value change
-
+$211,832,000
-
Number of buys
-
44
Institutional Holders of Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) as of Q1 2015
As of 31 Mar 2015,
Cellectis S.A. - Ordinary Shares, nominal value EUR0.05 per share (CLLS) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,124,463 shares.
The largest 10 holders included
FMR LLC, JPMORGAN CHASE & CO, PRICE T ROWE ASSOCIATES INC /MD/, ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, LAZARD ASSET MANAGEMENT LLC, BlackRock Advisors LLC, DEERFIELD MANAGEMENT CO, Artal Group S.A., and BlackRock Group LTD.
This page lists
44
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.